Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 194.92M | $ 172.19M | 88.34% |
3/31/2025 | $ 196.18M | $ 168.48M | 85.88% |
12/31/2024 | $ 213.33M | $ 166.06M | 77.84% |
9/30/2024 | $ 220.72M | $ 168.76M | 76.46% |
6/30/2024 | $ 205M | $ 160.15M | 78.12% |
3/31/2024 | $ 214.15M | $ 166.44M | 77.72% |
12/31/2023 | $ 230.53M | $ 172.96M | 75.03% |
9/30/2023 | $ 203.6M | $ 173.94M | 85.43% |
6/30/2023 | $ 200.49M | $ 175.71M | 87.64% |
3/31/2023 | $ 196.26M | $ 177.6M | 90.5% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for PUMA BIOTECHNOLOGY INC is calculated as follows: GP [ $ 196.9M ] / Assets [ $ 261.69M ]
(=) GPA [ 75.24% ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |